Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: Special references to HIF-1 dependent gene expression of profibrogenic molecules.
Kabei K, Tateishi Y, Nozaki M, Tanaka M, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Tomita S, Miura K. Kabei K, et al. Among authors: tomita s. J Pharmacol Sci. 2018 Jan;136(1):31-38. doi: 10.1016/j.jphs.2017.12.004. Epub 2017 Dec 28. J Pharmacol Sci. 2018. PMID: 29352658 Free article.
A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, Tomita S, Iwao H, Izumi Y. Yamaguchi T, et al. Among authors: tomita s. J Pharmacol Sci. 2019 Feb;139(2):112-119. doi: 10.1016/j.jphs.2018.12.004. Epub 2018 Dec 18. J Pharmacol Sci. 2019. PMID: 30638989 Free article.
Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model.
Kabei K, Tateishi Y, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Matsunaga S, Yamaguchi T, Tomita S, Miura K. Kabei K, et al. Among authors: tomita s. J Pharmacol Sci. 2020 Mar;142(3):93-100. doi: 10.1016/j.jphs.2019.12.002. Epub 2019 Dec 6. J Pharmacol Sci. 2020. PMID: 31866051 Free article.
Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice.
Nishide S, Uchida J, Matsunaga S, Tokudome K, Yamaguchi T, Kabei K, Moriya T, Miura K, Nakatani T, Tomita S. Nishide S, et al. Among authors: tomita s. J Pharmacol Sci. 2020 Jun;143(2):122-126. doi: 10.1016/j.jphs.2020.02.010. Epub 2020 Mar 3. J Pharmacol Sci. 2020. PMID: 32199747 Free article.
1,332 results